Deep Longevity Revenue and Competitors

Claim your profile

Hong Kong, China

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Deep Longevity's estimated annual revenue is currently $1M per year.(i)
  • Deep Longevity's estimated revenue per employee is $91,591

Employee Data

  • Deep Longevity has 11 Employees.(i)
  • Deep Longevity grew their employee count by 0% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$10.7M113-14%$312.8MN/A
#2
$3.4M44N/AN/AN/A
#3
$46.4M383-20%N/AN/A
#4
$1M110%N/AN/A
#5
$2M220%N/AN/A
#6
$22.1M2406%N/AN/A
#7
$5.9M10032%N/AN/A
#8
$5M532%$179.7MN/A
Add Company

Deep Longevity is developing explainable artificial intelligence systems to track the rate of aging at the molecular, cellular, tissue, organ, system, physiological, and psychological levels. It is also developing systems for the emerging field of longevity medicine enabling physicians to make better decisions on the interventions that may slow down, or reverse the aging processes. Deep Longevity developed Longevity as a Service (LaaS)© solution to integrate multiple deep biomarkers of aging dubbed “deep aging clocks” to provide a universal multifactorial measure of human biological age. Originally incubated by Insilico Medicine, Deep Longevity started its independent journey in 2020 after securing a round of funding from the most credible venture capitalists specializing in biotechnology, longevity, and artificial intelligence. ETP Ventures, Human Longevity and Performance Impact Venture Fund, BOLD Capital Partners, Longevity Vision Fund, LongeVC, co-founder of Oculus, Michael Antonov, and other expert AI and biotechnology investors supported the company. Deep Longevity established a research partnership with one of the most prominent longevity organizations, Human Longevity, Inc. to provide a range of aging clocks to the network of advanced physicians and researchers.

keywords:N/A

N/A

Total Funding

11

Number of Employees

$1M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Deep Longevity News

2022-04-06 - Matthias Mann to present at the 9th Aging Research & Drug ...

Deep Longevity Ltd ... 2022 - Matthias Mann, Ph.D., will present the latest research on the topic Single cell and Deep Visual Proteomics and...

2022-03-30 - 9th ARDD packed with more than 70 leaders in aging and ...

The Scheibye-Knudsen Lab, University of Copenhagen and Deep Longevity have revealed the longevity leaders speaking at the 9th Aging Research...

2022-03-30 - Tim Peterson to present at the 9th Aging Research & Drug ...

Deep Longevity Ltd ... At ARDD, leaders in the aging, longevity, and drug discovery field will describe the latest progress in the molecular...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.4M11-8%N/A
#2
$0.5M110%N/A
#3
$1M11N/AN/A
#4
$0.9M120%N/A
#5
$0.8M120%N/A